Analysis of Devices Authorized by the FDA for Clinical Decision Support in Critical Care

Jessica T Lee; Alexander T Moffett; George Maliha; Zahra Faraji; Genevieve P Kanter; Gary E Weissman

doi:10.1001/jamainternmed.2023.5002

Analysis of Devices Authorized by the FDA for Clinical Decision Support in Critical Care

JAMA Intern Med. 2023 Dec 1;183(12):1399-1401. doi: 10.1001/jamainternmed.2023.5002.

Authors

Jessica T Lee^{1

2

3}, Alexander T Moffett^{1

2

3}, George Maliha^{3

4}, Zahra Faraji¹, Genevieve P Kanter^{5

6}, Gary E Weissman^{1

2

3

7}

Affiliations

¹ Palliative and Advanced Illness Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
³ Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
⁴ Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
⁵ Department of Health Policy and Management, Sol Price School of Public Policy, University of Southern California, Los Angeles.
⁶ Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
⁷ Penn Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

No abstract available

Plain language summary

This case series study examines the clinical evidence cited for US Food and Drug Administration–approved clinical decision support devices for use in the critical care setting.

Publication types

Comment

MeSH terms

Artificial Intelligence
Critical Care
Decision Support Systems, Clinical*
Device Approval / legislation & jurisprudence
Humans
United States
United States Food and Drug Administration